Utility of Minimally Invasive Treatment for Papillary Microcarcinoma, Acknowledging Most Require No Treatment at All. Alexander EK. J Clin Endocrinol Metab 2020;105.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Alexander EK. Utility of Minimally Invasive Treatment for Papillary Microcarcinoma, Acknowledging Most Require No Treatment at All. J Clin Endocrinol Metab 2020;105.
PMID: 32301488